Rasona, Maria Luz B.

HRN: 24-05-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
AMPICILLIN 1GM (VIAL)
11/09/2023
11/15/2023
IV
2gms
Q6H
PROM
Waiting Final Action 
11/09/2023
CEFUROXIME 1.5GM (VIAL)
11/09/2023
11/10/2023
IVT
1.5 G
Q8
S/P Primary CS
Waiting Final Action 
11/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/09/2023
11/10/2023
IVT
500mg
Q8
S/P Primary CS
Waiting Final Action 
11/10/2023
CEFUROXIME 500MG (TAB)
11/10/2023
11/17/2023
PO
1 Tab
BID
S/p CS
Waiting Final Action 
11/10/2023
METRONIDAZOLE 500MG (TAB)
11/10/2023
11/17/2023
PO
1 Tab
TID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: